全文获取类型
收费全文 | 10314篇 |
免费 | 952篇 |
国内免费 | 382篇 |
专业分类
耳鼻咽喉 | 116篇 |
儿科学 | 193篇 |
妇产科学 | 178篇 |
基础医学 | 1483篇 |
口腔科学 | 132篇 |
临床医学 | 1215篇 |
内科学 | 1597篇 |
皮肤病学 | 445篇 |
神经病学 | 537篇 |
特种医学 | 487篇 |
外国民族医学 | 7篇 |
外科学 | 921篇 |
综合类 | 836篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 644篇 |
眼科学 | 279篇 |
药学 | 1339篇 |
5篇 | |
中国医学 | 479篇 |
肿瘤学 | 750篇 |
出版年
2024年 | 20篇 |
2023年 | 138篇 |
2022年 | 371篇 |
2021年 | 455篇 |
2020年 | 319篇 |
2019年 | 370篇 |
2018年 | 387篇 |
2017年 | 333篇 |
2016年 | 428篇 |
2015年 | 588篇 |
2014年 | 697篇 |
2013年 | 646篇 |
2012年 | 1008篇 |
2011年 | 947篇 |
2010年 | 543篇 |
2009年 | 463篇 |
2008年 | 599篇 |
2007年 | 551篇 |
2006年 | 424篇 |
2005年 | 434篇 |
2004年 | 315篇 |
2003年 | 296篇 |
2002年 | 237篇 |
2001年 | 128篇 |
2000年 | 134篇 |
1999年 | 147篇 |
1998年 | 87篇 |
1997年 | 88篇 |
1996年 | 57篇 |
1995年 | 63篇 |
1994年 | 39篇 |
1993年 | 32篇 |
1992年 | 52篇 |
1991年 | 36篇 |
1990年 | 31篇 |
1989年 | 26篇 |
1988年 | 22篇 |
1987年 | 25篇 |
1986年 | 12篇 |
1985年 | 16篇 |
1984年 | 5篇 |
1983年 | 10篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1979年 | 8篇 |
1970年 | 7篇 |
1968年 | 3篇 |
1966年 | 6篇 |
1965年 | 3篇 |
1935年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
Anatomical considerations of selective pudendal neurectomy 总被引:3,自引:0,他引:3
The pudendal nerve was examined in 100 cadavers of both sexes. Because of the variable number of trunks of the pudendal nerve,
5 types were distinguished: one-trunked; two-trunked, rectopudendal; two-trunked, pudendo-penile (or-clitoridal); three-trunked,
recto-perineo-penile (or-clitoridal); four-trunked, recto-perineo-perineopenile (or-clitoridal).
The authors' suggestions make it possible to perform selective pudendectomy, consisting in denervation of the sphincter urethrae
muscle by neurectomy of the perineal branches of the pudendal nerve. 相似文献
7.
Adult female rats were i.p. infused (Alzet osmotic minipumps) with neurotensin (NT, 2 micrograms/rat/day for 7 days), arginine-vasopressin (AVP, 2 micrograms/rat/day for 8 days), bombesin (BM, 0.75 microgram/rat/day for 7 days) or injected with neuropeptide Y (NPY, 0.5 microgram/rat twice a day for 4 days). NT infusion increased absolute and relative thyroid gland weight and decreased serum T4 level, while serum TSH and T3 levels remained unchanged. AVP treatment increased thyroid gland weight and serum TSH and T4 levels and a similar effect was induced by prolonged BM infusion. On the other hand, NPY administration had no effect either on thyroid gland weight or on serum TSH, T4 and T3 levels. Results of the present study thus clearly demonstrate a potent stimulatory action of AVP and BM on thyroid gland function and suggest that this effect is mediated by the pituitary gland. On the contrary, prolonged NT infusion decrease serum T4 level while NPY had no effect on thyroid gland function. 相似文献
8.
9.
Hypoxiaisadirectfactorcausinghypoxicpul monaryhypertension (HPH) .hypoxiainduciblefac tor 1α (HIF 1α)isfoundtobethemostcrucialfactorsofarwhichmediatesthecellularresponsetohypoxi a[1] .OurpreviousstudyrevealedthatoverexpressionofHIF 1andendothelin 1(ET 1… 相似文献
10.
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. 总被引:3,自引:0,他引:3
Pavel Sova Xiao-Wei Ren Shaoheng Ni Kathrin M Bernt Jie Mi Nancy Kiviat André Lieber 《Molecular therapy》2004,9(4):496-509
We have constructed a new capsid-modified adenovirus (Ad) vector that specifically replicates in tumor cells and expresses TNF-related apoptosis-inducing ligand (TRAIL). The Ad capsid contains short-shafted fibers derived from Ad serotype 35, which allow for efficient infection of malignant tumor cells, and largely avoids innate toxicity after intravenous application. Replication-dependent homologous recombination in Ad genomes was used to achieve tumor-specific expression of Ad E1a (to mediate viral replication) and TRAIL (to mediate apoptosis and enhance release of progeny virus from infected cells). We demonstrated that our oncolytic vector (Ad5/35.IR-E1A/TRAIL) induced apoptosis in human tumor cell lines derived from colorectal, lung, prostate, and liver cancer. Both in vitro and in vivo tumor models showed efficient intratumoral spread of this vector. In a model for metastatic colon cancer, tail vein infusion of Ad5/35.IR-E1A/TRAIL resulted in elimination of preestablished liver metastases. Intravenous injection of this vector caused a transient elevation of serum glutamic pyruvic transaminase in tumor-bearing mice, which we attributed to factors released from apoptotic tumor cells. Liver histology analyzed at day 14 after virus injection did not show signs of hepatocellular damage. This new oncolytic vector represents a potentially efficient means for gene therapy of metastatic cancer. 相似文献